CorMatrix Cardiovascular, Inc.
USPTO PatentsView assignee record - 85 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).
The verdict
According to USPTO PatentsView, Cormatrix ranks #4,190 of 49,997 tracked US assignees by granted-patent volume, with 85 patents across 9 technology areas.
- #4,190
- of 49,997 US assignees by volume
- 43rd percentile
- by Innovation Score (33.0/100)
- 7.2
- avg claims per patent
- -80%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4190 · US Corporation #4,190 · 85 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 85 grants
- TOP-DECILE #4,190/49,997
- PHOTO-FINISH Changzhou University
- CPC-NARROW A61L · 9 areas
- INNOV-THIN 33.0/100
- CLAIMS-SPARSE 7.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -80% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Changzhou University (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Cormatrix’s 33.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Cormatrix
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Klemm + Sohn & KG · near 33
Klemm + Sohn & KG · near
33 score
- CorMatrix Cardiovasc… · this assignee 33
CorMatrix Cardiovasc… · this assignee
33 score
- Rockler Companies · near 33
Rockler Companies · near
33 score
- Semilab Semiconducto… · near 33
Semilab Semiconducto… · near
33 score
- Vricon Systems… · near 33
Vricon Systems… · near
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Cormatrix's Innovation Score is 33.0/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Cormatrix?
Each dot is one of Cormatrix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cormatrix’s own 7.2 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Cormatrix's grants concentrate
CorMatrix Cardiovascular, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 88.2% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2015 (21 grants) versus a trough of 4 in 2020. By volume, Cormatrix sits between Changzhou University and Given Imaging Ltd..
Cormatrix's three-year grant acceleration
CorMatrix Cardiovascular, Inc. shows 6 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at CorMatrix's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Changzhou Univers…
Changzhou University
85 patents
- Chemetall
Chemetall GMBH
85 patents
- Construction Rese…
Construction Research & Technology GMBH
85 patents
- Cooper-standard A…
Cooper-Standard Automotive Inc.
85 patents
- Digitalglobe
Digitalglobe Inc
85 patents
- Flint Hills Scien…
Flint Hills Scientific, L.L.C.
85 patents
- Genmab A/S
Genmab A/S
85 patents
- Given Imaging
Given Imaging Ltd.
85 patents
- Cormatrix Cardiov… ◀
CorMatrix Cardiovascular, Inc.
85 patents
What this shows CorMatrix holds 85 patents at rank #4,190, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near CorMatrix
By rank, the assignees closest to #4,190 in granted patent volume.
- Changzhou University #4,186 · 85 patents
- Chemetall GMBH #4,187 · 85 patents
- Construction Research & Technology GMBH #4,188 · 85 patents
- Cooper-Standard Automotive Inc. #4,189 · 85 patents
- Digitalglobe Inc #4,191 · 85 patents
- Flint Hills Scientific, L.L.C. #4,192 · 85 patents
- Genmab A/S #4,193 · 85 patents
- Given Imaging Ltd. #4,194 · 85 patents
Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)
Other assignees with the most granted patents in CorMatrix's primary technology class.
- The Procter & Gamble Company 378 in class
- Ethicon, Inc. 277 in class
- Abbott Cardiovascular Systems, Inc. 252 in class
- Boston Scientific Scimed, Inc. 240 in class
- Covidien LP 174 in class
- Warsaw Orthopedic, Inc. 167 in class
- DePuy Synthes Products, Inc. 161 in class
- W.L. Gore & Associates GmbH 146 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for CorMatrix, neither rank-band nor same-CPC leaders (those blocks stay above). In A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…), CorMatrix ranks #28 of 2,589 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (33 here).
Similar claim depth
Nearest assignees by average claims per patent (7.2 here).
Cormatrix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 43rd percentile higher than 43% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 21 | 24.7% |
| 2016 | 16 | 18.8% |
| 2017 | 19 | 22.4% |
| 2018 | 7 | 8.2% |
| 2019 | 7 | 8.2% |
| 2020 | 4 | 4.7% |
| 2021 | 4 | 4.7% |
| 2024 | 6 | 7.1% |
| 2025partial year | 1 | 1.2% |
Which technologies does CorMatrix Cardiovascular, Inc. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
CorMatrix Cardiovascular, Inc.'s patent record in context - here's where to go next.
- CorMatrix Cardiovascular, Inc.'s lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 88.2% of its portfolio - see every assignee active in that class. Explore A61L
- Ranked #4,190 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare CorMatrix Cardiovascular, Inc. against Changzhou University, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.